TABLE 4.

Proportion of patients referred for genetic counseling by test type

	No. of patients who underwent CGP test		No. of patients recommended for genetic counseling		No. of patients who received genetic counseling
	T‐only analysis	T/N paired analysis	T‐only analysis (%)	T/N paired analysis (%)	T‐only analysis (%)	T/N paired analysis (%)
A	195	18	28 (14.4%)	3 (16.7%)	13 (46.4%)	3 (100%)
B	264	10	21 (8.0%)	0 (0.0%)	21 (100%)	0 (‐)
C	59	48	1 (1.7%)	2 (4.2%)	1 (100%)	1 (50.0%)
D	141	58	13 (9.2%)	3 (5.2%)	13 (100%)	3 (100%)
E	383	28	27 (7.0%)	0 (0.0%)	14 (51.9%)	0 (‐)
F	255	367	17 (6.7%)	10 (2.7%)	5 (29.4%)	7 (70.0%)
G	48	48	6 (12.5%)	3 (6.3%)	6 (100%)	3 (100%)
H	293	10	37 (12.6%)	0 (0.0%)	9 (24.3%)	0 (‐)
I	138	17	25 (18.1%)	0 (0.0%)	7 (28.0%)	0 (‐)
J	226	19	20 (8.8%)	0 (0.0%)	10 (50.0%)	0 (‐)
K	246	26	21 (8.5%)	2 (7.7%)	12 (57.1%)	2 (100%)
L	143	8	23 (16.1%)	0 (0.0%)	12 (52.2%)	0 (‐)
Total	2391	657	239 (10.0%)	23 (3.5%)	123 (51.5%)	19 (82.6%)

Note: T‐only analysis: only tumor samples evaluated; T/N paired analysis: paired tumor/normal samples evaluated.

Abbreviation: CGP, comprehensive genomic profiling.